Page 2 - Aaron Ring News Today

/PRNewswire/ -- The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its...

/PRNewswire/ -- The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

It's not clear why some people who get COVID-19 are plagued with symptoms for many months after being infected, but scientists are investigating what's behind these "long haul" cases.

Rogue antibodies are major culprits in severe cases of COVID-19, researchers report. These autoantibodies target and react with a person’s tissues or organs similar to ones that cause autoimmune diseases such as lupus or rheumatoid arthritis. In COVID-19 cases they can attack healthy tissue in brain, blood vessels, platelets, liver, and the gastrointestinal tract, researchers report. The more autoantibodies detected, the greater the disease severity patients experience. And the autoantibodies...

By Bill Hathaway May 19, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) The development of antibodies to the COVID-19 virus has been the great long-term hope of ending the pandemic. However, immune system turncoats are also major culprits in severe cases of COVID-19, Yale scientists report in the journal Nature. These autoantibodies target and react with a person’s tissues or organs similar to ones that cause au...

Fox News Flash top headlines are here. Check out whats clicking on Foxnews.com. New findings out from Yale University suggest autoantibodies — or proteins acting against a person’s own tissues and organs — may correlate with COVID-19 severity and lasting symptoms. In some coronavirus cases, these autoantibodies can fight healthy tissue in the liver, brain, gastrointestinal tract, blood vessels and platelets, researchers found. A team of researchers at the university published findings on ...

May 10, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.” The study is led by Yale faculty members Akiko Iwasaki, Aaron Ring, Wade Schulz, Charles Dela Cruz, Erica Spatz, and Harlan Krumholz. The idea for...

May 10, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.” The study is led by Yale faculty members Akiko Iwasaki, Aaron Ring, Wade Schulz, Charles Dela Cruz, Erica Spatz, and Harlan Krumholz. The idea for...

Milwaukee, WI (PRWEB) April 14, 2021 -- The Society for Immunotherapy of Cancer (SITC) will host a new workshop Oct. 11–12, 2021, in New York, which will